Pharm manuf/distr DIV - FSA
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- SPE2D225D0013
- Awardee
-
Avkare LLC UEI SFPGXE6XPS93
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Task orders
- 0
Award facts
- Opportunity
-
- Lamotrigine PreSolicitation Pre-Solicitation · SPE2D225R0002 · Posted Oct 31, 2024
- Last date to order 30% complete
- IDV ceiling
- $15,978,181.35
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Defense Logistics Agency Troop Support Medical awarded a single-award indefinite-delivery contract to Avkare LLC on May 13, 2025, with a ceiling of $15,978,181.35 and an ultimate completion date of May 12, 2030. No set-aside applies; the contract is fully competed on an unrestricted basis.
The contract covers pharmaceutical manufacturing and distribution services under NAICS 325412 (Pharmaceutical Preparation Manufacturing) and PSC 4610121118. Place of performance is Pulaski, Tennessee.
The originating solicitation, posted October 31, 2024, with proposals due January 9, 2025, sought a national requirements contract for Lamotrigine ER Tablets in multiple strengths (25 mg to 300 mg) in 30-count bottles. The procurement establishes a national supply source for the Department of Defense, Bureau of Prisons, Indian Health Service, and Department of Veterans Affairs customers through DLA and VA prime vendor programs. The solicitation structured the award as a firm-fixed-price, requirements-type contract with a one-year base period and four one-year options, with proposals evaluated under FAR Part 12 as commercial items.
The contract is one element of Avkare's broader pharmaceutical supply portfolio with DLA and the VA. Recent related single-award IDCs issued to Avkare include contracts for Metformin Hydrochloride 24-hour sustained-release tablets ($90.7 million ceiling, December 2025), Telmisartan tablets ($64.6 million ceiling, December 2025), and Potassium Chloride Extended Release tablets ($39.51 million ceiling, October 2025). Delivery-order activity under these and other Avkare pharmaceutical IDCs flows primarily through DLA Troop Support Medical and VA regional networks, with individual orders typically ranging from under one hundred dollars to several thousand dollars per pharmaceutical product.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract SPE2D225D0013?
SPE2D225D0013 was awarded to Avkare LLC by Medical Supply Chain (Troop Support) on May 13, 2025.
How much is contract SPE2D225D0013 worth?
SPE2D225D0013's own ceiling is $15,978,181.
Who can order from contract SPE2D225D0013?
SPE2D225D0013 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract SPE2D225D0013 competed?
The extent of competition for SPE2D225D0013 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV